Back to speakers

Elisabetta BUGIANESI



City: Torino

Institution: University of Torino, Italy / Medical Sciences Department

Biography of Elisabetta BUGIANESI

Prof. Elisabetta Bugianesi MD, PhD, is a clinical researcher graduated from the School of Medicine of the University of Bologna, Italy. He became specialist in Internal Medicine and later PhD in Hepatology at the University of Bologna and Modena. Her post-graduate training included a PhD fellowship at the Cleveland Clinic and at Case Western Reserve University, Cleveland, USA, from 1995 to 1998 where she became expert in the use of stable isotopes to study in vivo metabolism and started a pioneering research activity on NAFLD under the guidance of Prof AJ McCullough.

She is an international acknowledged expert on Non-Alcoholic Fatty Liver Disease (NAFLD) with over 15 years’ experience in the field where she has made a particular impact with work describing the metabolic mechanisms of insulin resistance related to the onset and progression of liver damage, the natural history of the disease including the first demonstration of HCC as a complication of NASH-related liver disease, the development of non-invasive markers of fibrosis including the NAFLD Fibrosis score, currently recommended by the EASL-EASD-EASO Clinical practice Guidelines on NAFLD (J Hepatology, 2016) and the involvement in several trials for the treatment of NAFLD/NASH. She has been national principal investigator of FP7 funded Fatty Liver: Inhibition of Progression (FLIP) consortium (2010-2013), assembling the largest cohort to date of highly phenotyped, histologically characterized patients with NAFLD for the genetics work-package and she is currently involved in other two major EU funded research consortia: ‘EPoS’ Elucidating Pathways of Steatohepatitis (EU H2020 funded €6 million, 2015-2019) and ‘LITMUS’ Liver Investigation: Testing Marker Utility in Steatohepatitis (EU IMI2 funded €34 million, 2017-2022), where she has the role of national lead for Italy. As clinician, she is a practicing Hepatologist based at the GI Division of the University Hospital “Città della Salute e della Scienza of Torino”, Italy, where she is the lead physician for the Hepatology Outpatient Clinic (with about 1500 patients/year) and the Head of the Gastro-hepatology Laboratory. Contributions to Science 182 publications Impact Factor = 1274 H Index (1990-2017) = 49 (Scopus) N. Citations (1990-2017) = 14584 (Scopus) Positions and Honours Present appointment: Associate Professor of Gastroenterology. Dept of Medical Sciences, Division of Gastroenterology, University of Torino, Italy. International fellowships – PhD Fellow c/o Gastroenterology and Hepatology Division della Cleveland Clinic (Prof AJ McCullough) e c/o Laboratorio di Metabolismo/Spettrometria di Massa (Prof SC Kalhan) della Case Western Reserve University (CWRU), Cleveland (OH), USA (1995 – 1998) Editorial Boards: – Associate Editor of Journal of Hepatology – (2014 – current) – Web editor of Journal of Hepatology – (2011-2014) – Member of the Editorial Board of Hepatology – Member of the Editorial Board of Liver International – Member of the Editorial Board of Digestive and Liver Disease Memberships – Ordine dei Medici (Italy). – Associazione Italiana per lo Studio del Fegato (AISF), member of the AISF NAFLD Expert Committee (AISF) – Associazione Italiana Gastroenterologi Ospedalieri (AIGO), Member of the Scientific Commette – European Association for the Study of the Liver (EASL). – American Association for the Study of the Liver (AASLD)


PHC's participations

12th PHC – 2019

Monday, January 14th 2019

Is change of life style councelling efficient? -